Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Int J Surg Pathol. 2016 Aug 4;25(2):100–107. doi: 10.1177/1066896916662154

Table 3.

Summary of Patients With Subsequent Ipsilateral Breast Carcinoma (Invasive Carcinoma or DCIS).

Characteristics Case 1 Case 2 Case 3 Case 4
Clinical
 Age (years) at diagnosis of ADH/DCIS 48 42 52 83
 Menopausal status Premenopausal Premenopausal Postmenopausal Postmenopausal
 Family history of breast cancer Yes, second degree No No Yes, first degree
 Indication for biopsy Calcifications Calcifications MRI abnormality Calcifications
 Adjuvant therapy None None None None
Pathological
 ADH/DCIS diagnosis Core biopsy only Core biopsy only Excision Core biopsy only
 ADH/DCIS size, mm 2 1 2 1
 No. of ducts involved >2 >2 >2 2
 Predominant architecture Flat Micropapillary Cribriform Micropapillary
 Nuclear grade 1–2 1 1–2 1
 Classic LCIS or ALH Yes No Yes No
 Final margin status Negative Negative Negative Negative
 Consensus diagnosis ADH ADH ADH ADH
 Interobserver agreement 3 of 5 4 of 5 4 of 5 4 of 5
Subsequent ipsilateral breast carcinoma
 Interval, years 3 10 4 1
 Histology DCIS DCIS Invasive ductal Invasive ductal ca with focal mucin
 Site in relation to ADH/DCIS Same quadrant Same quadrant Same quadrant Different quadrant
 Histological grade Not applicable Not applicable III III
 Nuclear grade High Intermediate II II
 Size, cm 0.8 Not available 1.2 2
 Receptor status Not available ER+ ER+, PR−, HER2− ER+, PR+, HER2−

Abbreviations: ADH, atypical ductal hyperplasia; ALH, atypical lobular hyperplasia; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; MRI, magnetic resonance imaging.